Cutaneous melanoma cell line MEL 94.07 has an inactivating mutation in TP53 gene, which indeed coincides with no observed changes in the mRNA levels of the analyzed genes upon Nutlin-3 treatment. The gene discussed is TP53; the disease is cutaneous melanoma.